The success of Viagra initially sparked a period of growth for pharma, however recent developments present a uncertain scenario for those considering a stake. Generic alternatives are eroding revenue, and continued https://kianaanzg355111.blog2news.com/41696816/the-blue-pill-and-pharma-a-risky-investment